Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Vaxcyte to Participate in Upcoming Investor Conferences

Vaxcyte to Participate in Upcoming Investor Conferences

Vaxcyte, Inc., a clinical-stage US vaccine company, announced its participation in upcoming investor conferences where it will present its pipeline of advanced vaccine candidates. Their lead candidates, VAX-31 and VAX-24, target broad protection against invasive pneumococcal disease, with additional vaccines in development including VAX-A1 for Grou…

Beacon Financial Corporation Announces Second Quarter 2026 Earnings Release Date and Conference Call

Beacon Financial Corporation Announces Second Quarter 2026 Earnings Release Date and Conference Call

Beacon Financial Corporation, a regional bank holding company based in Boston serving the Northeast, will report its second quarter 2026 earnings following market close on July 29, 2026. Management will host a conference call on July 30 to discuss the results. The company provides a range of banking services including commercial, retail, SBA lendin…

Destination XL Group, Inc. Recommends DXL Stockholders Reject Zodiac Partners II's Revised, Unsolicited Tender Offer and NOT Tender Their Shares

Destination XL Group, Inc. Recommends DXL Stockholders Reject Zodiac Partners II's Revised, Unsolicited Tender Offer and NOT Tender Their Shares

The Board of Directors of Destination XL Group, Inc. (NASDAQ: DXLG) unanimously recommends shareholders reject Zodiac Partners II's revised unsolicited tender offer of $0.84 per share. The Board considers the offer undervalued and opportunistic amid current market conditions, emphasizing commitment to maximizing shareholder value.

Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101

Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101

Tarsus Pharmaceuticals has acquired clinical-stage iRenix Medical, gaining the investigational ocular antiseptic IRX-101, which demonstrated positive Phase 2b/3 results in reducing post-procedural pain and corneal toxicity in patients receiving intravitreal therapy. The acquisition strengthens Tarsus's leadership in innovative eye care, providing a…

Seanergy Maritime Announces Pricing of €100 Million Unsecured Corporate Bond trading on Euronext Athens

Seanergy Maritime Announces Pricing of €100 Million Unsecured Corporate Bond trading on Euronext Athens

Seanergy Maritime Holdings Corp., a U.S.-listed shipping company specializing in Capesize vessels, announced the pricing of €100 million unsecured bonds to be traded on Euronext Athens. The bonds mature in 2031 with a 4.90% coupon. Proceeds will be used for new vessel acquisitions and general corporate purposes, enhancing the company's capital stru…

Cheer Holding, Inc.

Cheer Holding, Inc.

Cheer Holding, Inc., a leading provider of next-generation mobile internet infrastructure and platform services, announced the results of its 2026 Annual General Meeting held in Beijing. Key resolutions included the re-election of two directors, ratification of their accounting firm, approval to increase authorized share capital significantly, and …

Pure Cycle Announces Financial Results For the Three and Nine Months Ended May 31, 2026 and Announces a Board of Directors Transition

Pure Cycle Announces Financial Results For the Three and Nine Months Ended May 31, 2026 and Announces a Board of Directors Transition

Pure Cycle Corporation reported a 60% increase in quarterly revenues and 31% increase in net income for Q3 2026 compared to the prior year, driven by robust performance in land development and increased water sales to oil and gas customers. The company achieved its 28th consecutive profitable fiscal quarter, is advancing development phases at its S…